Table 1.
Patient characteristics.
Table 2.
Clinical indications for 18F-FDG PET/CT.
Fig 1.
Clinical impact of 18F-FDG PET/CT on diagnostic and/or treatment management.
Fig 2.
Impact of 18F-FDG PET/CT on diagnostic management.
MIP PET (A) and representative PET-CT fused coronal (B) plane. Hypermetabolic 3.4 cm left upper lobe mass-like pulmonary opacity with SUVmax 9.8 (see red arrow). Multifocal hypermetabolic mediastinal and bilateral hilar lymphadenopathy with SUVmax 15.4. Multiple hypermetabolic splenic lesions with SUVmax 17.2. The biopsy of lung mass showed non-necrotizing granuloma, suggestive of sarcoidosis.
Table 3.
Clinical impact of 18F-FDG PET/CT by indication and by presence of foreign material.
Fig 3.
18F-FDG PET/CT impact on diagnosis of vascular graft infection.
Representative CT (A), PET (B) and PET-CT fused (C) images. Long segment (approximately 15 cm) of hypermetabolism in the right side of the patient’s aortoiliac graft consistent with infected clot (see red arrows). The clot extends from near the bifurcation to just proximal to the patient’s femorofemoral bypass insertion. Findings are most consistent with vascular graft infection. There is normal blood pool activity along left side aortoiliac graft.
Table 4.
SUVmax of 18F-FDG PET/CTs with impact on management.